collapse when worn during sleep. These devices reduce snoring, AHI and nocturnal oxygen desaturation and reduce objective and subjective sleepiness in patients with OSA, though not as effectively as CPAP. Not all patients respond to mandibular advancement devices. Short-term side-effects include temporomandibular joint discomfort and excess salivation. Occlusal changes may occur with long-term use, and regular dental reviews are recommended. Mandibular advancement devices probably have a role in patients who cannot or will not use CPAP, and in those with mild disease. Specialist orthodontic collaboration is recommended for appropriate prescription.
Drugs are generally unhelpful in OSAS. Tricyclic antidepressants (e.g. protriptyline) reduce REM sleep time and so may improve OSAS in patients with REM-predominant disease. However, anticholinergic side-effects limit their use, particularly in men.
Surgery -nasal surgery is seldom useful in OSAS. Surgery can be curative in OSAS in children and adolescents with adenotonsillar hypertrophy; adults may derive some benefit, but cure is rare. The postoperative period may be hazardous if OSA is untreated. Uvulopalatopharyngoplasty involves removal of the tonsils, the uvula and parts of the soft palate and pharyngeal folds. It is the most commonly performed surgical procedure in OSAS, but carries significant morbidity, and an AHI of less than 20 is achieved in fewer than 50% of patients. There are no reliable means of improving patient selection, and subsequent use of CPAP may be more difficult. Laser-assisted and radiofrequency ablation palatal procedures are not effective in the treatment of OSA.
Complex maxillofacial surgery may be effective in OSAS when performed by experienced groups; success rates of more than 90% have been reported. The procedure is performed in two stages -genioglossal advancement via a mandibular osteotomy, with uvulopalatopharyngoplasty and nasal surgery, followed by maxillomandibular osteotomy and advancement. There is significant associated morbidity, however, and the procedure is not widely available.
Tracheostomy is usually required only as a last resort in patients with severe or complicated OSAS who are unable to tolerate CPAP. It is effective, but carries significant morbidity, particularly in obese patients. 
FURTHER READING

Practice points
• OSAS is common and significantly affects daytime functioning • OSAS is not confined to patients with obesity • CPAP is the most effective available treatment for OSA • OSA is an independent risk factor for hypertension and other cardiovascular diseases, including coronary artery disease, stroke and congestive cardiac failure
Respiratory failure
Christopher B Cooper
The respiratory system has two principal purposes -to main tain adequate arterial PaO 2 , and to regulate arterial PaCO 2 and thereby maintain a stable acid-base state. Both are necessary to sustain normal tissue metabolism. Respiratory fail ure can be defined in two ways:
• failure of oxygenation, resulting in PaO 2 < 8.0 kPa • failure of ventilation, resulting in PaCO 2 > 6.7 kPa with ac compa ny ing acid-base changes.
Failure of oxygenation -the definition of respiratory failure takes account of the sig moi dal oxyhaemoglobin dis so ci a tion curve ( Figure 1 ) and recognizes that significant decreases in hae moglob in saturation (and thus arterial oxygen content) do not occur until PaO 2 is less than 8.0 kPa (SaO 2 90%). Oxygenation failure can re sult from poor alveolar ven ti la tion, dif fu sion ab nor mal i ty, ventilation/perfusion mismatch and/or shunt. When the cause is diffusion abnormality, ven ti la tion/perfusion mis match or shunt, and the individual can increase al ve o lar ven ti la tion in response to hypoxaemia, PaCO 2 is reduced and pH in creased.
Failure of ventilation -regulation of PaCO 2 depends on maintenance of adequate al ve o lar ventilation. There is a hyperbolic re la tion ship between PaCO 2 and alveolar ventilation, depending on the met a bol ic rate (Fig ure 2) . Hence, as alveolar ventilation decreases, PaCO 2 increases and vice versa. At rest, alveolar ventilation must be about 4.5 litres/minute to regulate PaCO 2 to 5.3 kPa.
Assuming that the arterial and alveolar partial pressures of carbon dioxide are equal:
PaCO 2 (kPa) = 115.VCO 2 VA where VCO 2 is metabolic carbon dioxide production in litres per minute at standard temperature and pressure, dry, and VA is alveolar ventilation in litres per minute at body temperature and pressure, saturated with water vapour.
According to the definition of respiratory failure, alveolar ventilation must decrease by about 20%, resulting in an increase in PaCO 2 from 5.3 kPa to 6.7 kPa. If acute, such a change would result in acute respiratory acidosis with a decrease in pH from 7.40 to 7.30 (see be low). When failure of ventilation results in failure of • Disorders of the lung parenchyma impair gas exchange abili ty as a result of diffusion abnormalities or ventilation/perfusion mismatch, and tend to increase the work of breathing because of reduced lung compliance.
• Disorders of the respiratory muscle pump lead to alveolar hypoventilation.
Pathophysiology
Failure of oxygenation Acute hypoxaemia reduces arterial oxygen content as de termined by the oxyhaemoglobin dissociation curve (Figure 1 ). Acute hypoxaemia can be life-threatening and is associated with loss of con scious ness; if it is severe or prolonged, severe ir re vers i ble hy pox ic encephalopathy occurs. It also causes pul mo nary va socon stric tion with a modest increase in pul mo nary artery pressure, and renal va so con stric tion with sec ond ary ef fects on renal function. At PaO 2 less than 8.0 kPa, ca rot id body stim u la tion in creas es respiratory drive. Un less the cause is alveolar hypoventilation, ventilation in creas es, caus ing PAO 2 to increase and PACO 2 to decrease.
Chronic hypoxaemia has important pathophysiological conse quenc es (polycythaemia, pulmonary hypertension and cor pulmonale). Hypoxaemia stimulates renal secretion of eryth ropoi e tin, increasing RBC production. Raised haematocrit in creas es the oxygen-carrying capacity of the blood (tends to com pen sate for reduced hae mo glob in sat u ra tion as so ci at ed with hy pox ae mia) and increases blood viscosity (com pro mis ing tis sue blood flow such that ve n e sec tion should be con sid ered when hae ma t ocrit > 55%). Chronic hypoxaemia has ad verse con se quenc es in the pul mo nary cir cu la tion. Pul mo nary arterioles and pre cap il lary ves sels are re mod elled by dep o si tion of lon gi tu di nal mus cle fi bres in the intima of the ves sels, and vessel nar row ing in creas es pul mo nary vascular resistance, lead ing to mod est ly increased pul mo nary artery pres sure. In creased afterload in the pul mo nary cir cu la tion even tu al ly leads to right ventricular hyper tro phy, which de fines cor pulmonale. The as so ci a tion between cor pul mo nale and pe riph er al oedema cannot be ex plained by simple haemo dy nam ic means. The mech a nisms are not fully un der stood.
Failure of ventilation
Acute failure results in respiratory acidosis with increased PaCO 2 and a decrease in pH. The reduced pH can lead to life-threatening cardiac dysrhythmias, most commonly multifocal atri al tach ycar dia. Hypercapnia caus es va sodil a ta tion, which ac counts for some of the clin i cal man i fes ta tions of acute ventilatory fail ure.
Chronic failure with prolonged hypercapnic res pi ra to ry acidosis leads to metabolic compensation by renal re ten tion of bicarbonate; thus, pH tends to return towards normal. This adap tive mechanism develops over several days and is probably com plete in about 2 weeks. Patients can tolerate chronic severe hy per cap nia with a rel a tive ly normal acid-base state, but are at risk of wors en ing respiratory acidosis in acute exacerbations of chron ic fail ure.
Interpretation of arterial blood gases
Hypoxaemia -normal PaO 2 when breathing room air at sea lev el declines with age, from about 13.3 kPa in childhood to about 9.3 kPa in the elderly, because of a subtle deterioration in gas exchange efficiency, lead ing to an increasing alveolar-arterial oxygen gradient (PAO 2 -PaO 2 ). Cal cu la tion of PAO 2 -PaO 2 allows hy pox ae mia caused by al ve o lar hypoventilation or al ti tude to be distinguished from other mechanisms such as diffusion impairment, ven ti la tion/perfusion mismatch and shunt. As sum ing normal PaCO 2 , PAO 2 when breath ing room air at sea level is about 13.3 kPa. PAO 2 = ((P B -6.3).0.21) -PaCO 2 R where P B is the barometric pressure in kPa, 6.3 is the partial pressure of water vapour in the al ve o lar com part ment at normal body temperature, 0.21 is the fractional con cen tra tion of oxygen in room air and R is the respiratory ex change ratio.
At sea level breath ing room air, PAO 2 = 20 -(5.3/0.8) = 13.3 kPa. The normal al ve o lar-arterial oxygen gra di ent can be pre dict ed from PAO 2 -PaO 2 = (0.044 x age) -0.3 kPa.
PAO 2 -PaO 2 is increased when hypoxaemia is caused by diffu sion impairment, ven ti la tion/perfusion mismatch or shunt.
It is not unusual for hy pox ae mia to stimulate ventilation of rel a tive ly normal areas of lung, re duc ing PaCO 2 , but when hypoxaemia is caused purely by alveolar hypoventilation, PAO 2 is de creased and PACO 2 in creased, and PAO 2 -PaO 2 should be normal.
(For example, a patient suffering opiate in tox i ca tion presents with pH 7.10, PaCO 2 10.7 kPa and PaO 2 6.0 kPa breath ing room air. PAO 2 is 6.7 kPa and PAO 2 -PaO 2 is only 0.67 kPa.)
Acid-base state -pH indicates whether there is a tendency towards acidity (ac i do sis) or alkalinity (alkalosis). PaCO 2 can be easily assessed to see if the change in this could account for the Most common causes pH change. If it does, res pi ra to ry disturbance is present. In the acute setting, every 0.13 kPa increase in PaCO 2 is associated with a 0.01 decrease in pH. A fur ther sim ple estimate can be used to assess whether the acid-base dis tur bance is acute or more com plex.
In acute metabolic disturbances, every 0.5 mmol/litre change in bicarbonate is associated with a 0.01 change in pH. pH (∆0.01) ∝ HCO 3 (∆0.5 mmol/litre)/PaCO 2 (∆0.13 kPa) (This is a modified Henderson-Hasselbalch equation showing changes that would be equivalent in a patient with acute respiratory or metabolic disturbance.)
In a patient with pH 7.34 and PaCO 2 8.0 kPa: • there is an acidosis • PaCO 2 could account for it • an acute increase in PaCO 2 of 2.7 kPa would reduce pH by 0.2, from 7.40 to 7.20. The fact that pH is 7.34 indicates that the respiratory acidosis is partially compensated. The bicarbonate concentration is estimated to be 31 mmol/litre (a 7 mmol/litre increase accounting for the compensatory 0.14 increase in pH). This simplified approach works well in everyday clinical practice. When a more me tic u lous method is de sired, an acid-base diagram can be used (Fig ure 4) .
Practice points
• Assess respiratory failure in terms of failure of oxygenation and failure of ventilation • The most common clinical causes are obstructive sleep apnoea, chronic obstructive pulmonary disease, pneumonia and neuromuscular disease • Interpret arterial blood gases in three steps -acidosis or alkalosis, primary respiratory change or not, and any compensatory change • Indications for intubation are airway protection, refractory hypoxaemia and uncompensated respiratory acidosis 4
Diagnosis
The clinical diagnosis of respiratory failure can be obvious in patients with acute respiratory distress, or more difficult in certain causes of chronic hypoxaemia or hypoventilation. Hypoxaemia leads to central cyanosis, in which circulating de ox y gen at ed haemoglobin is more than 5 g/dl (haemoglobin saturation < about 75% at normal haemoglobin concentrations). Note that cyanosis can occur in polycythaemia, though haemoglobin saturation is increased and arterial oxygen con tent is rel a tive ly normal. Cyanosis is also seen when methaemoglobin is present at more than 1.5 g/dl. Central cy a no sis is best seen in the lips and tongue. Pe riph er al cy a no sis usually oc curs in con junc tion with true cen tral cy a no sis, but can occur in de pend ent ly as a re sult of im paired pe riph er al cir cu la tion and is there fore un re li a ble as a sign of hy pox ae mia in eve ry day clin i cal prac tice.
Hypercapnia causes peripheral venous dilatation, tachycardia, increased cardiac output and a large-volume pulse. Se vere hypercapnia causes headache from cerebral va sodil a ta tion (of ten in the early morning on waking), and even pap il loede ma. Hypercapnia has direct effects on CNS function (asterixis, hyporeflexia, meiosis, confusion and coma -carbon dioxide nar co sis).
Specific physical signs may be present depending on the cause of respiratory failure. Chest wall deformities are often over looked on examination. Auscultation can be un in forma tive, even in the presence of chronic lung disease. Specific neu ro log i cal signs should be sought if neuromuscular disease is sus pect ed.
